PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in PMV Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- −1 vs. Q1 2025
- Shares held
- 34.7M
- −2.64M (−7.1%) vs. Q1 2025
- Total value
- $36.8M
- −$3.92M (−9.6%) vs. Q1 2025
- New holders
- 7
- 13 more added
- Sold out
- 8
- 20 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMVP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 64 | $45.9M |
| Q1 2026 | 69 | $45.8M |
| Q4 2025 | 63 | $46.8M |
| Q3 2025 | 64 | $52.5M |
| Q2 2025 | 54 | $36.8M |
| Q1 2025 | 55 | $40.7M |
| Q4 2024 | 70 | $58.8M |
| Q3 2024 | 74 | $58.2M |
| Q2 2024 | 93 | $65.6M |
| Q1 2024 | 99 | $72.7M |
| Q4 2023 | 98 | $144.0M |
| Q3 2023 | 104 | $333.0M |
| Q2 2023 | 106 | $324.0M |
| Q1 2023 | 113 | $245.7M |
| Q4 2022 | 115 | $474.5M |
| Q3 2022 | 120 | $692.3M |
| Q2 2022 | 105 | $870.9M |
| Q1 2022 | 99 | $1.15B |
| Q4 2021 | 105 | $1.10B |
| Q3 2021 | 92 | $1.31B |
| Q2 2021 | 86 | $1.44B |
| Q1 2021 | 81 | $1.31B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding PMV Pharmaceuticals, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 450 | $0 | 0.00% | +66+17.2% | Added |
| Simplex Trading, LLC | 71 | $0 | 0.00% | +71 | New |
| Raymond James Financial Inc | 200 | $212 | 0.00% | +200 | New |
| BNP Paribas Arbitrage, SA | 545 | $578 | 0.00% | +1+0.2% | Added |
| JPMorgan Chase & Co | 914 | $969 | 0.00% | −10,535−92.0% | Reduced |
| Jones Financial Companies LLLP | 1,016 | $1.09K | 0.00% | +16+1.6% | Added |
| Tower Research Capital LLC (TRC) | 3,688 | $3.91K | 0.00% | +2,968+412.2% | Added |
| Group One Trading, L.P. | 7,396 | $7.84K | 0.00% | −3,900−34.5% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 8,790 | $9.32K | 0.00% | +8,790 | New |
| CI Private Wealth, LLC | 10,000 | $10.6K | 0.00% | 00.0% | Unchanged |
| Independent Advisor Alliance | 12,500 | $13.3K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 16,210 | $17.2K | 0.00% | −109,794−87.1% | Reduced |
| Pathstone Holdings, LLC | 17,487 | $18.5K | 0.00% | +17,487 | New |
| Citigroup Inc | 19,296 | $20.5K | 0.00% | −14−0.1% | Reduced |
| Squarepoint Ops LLC | 20,905 | $22.2K | 0.00% | −991−4.5% | Reduced |
| HRT Financial LP | 22,437 | $23.0K | 0.00% | +22,437 | New |
| Schonfeld Strategic Advisors LLC | 22,292 | $23.6K | 0.00% | −608−2.7% | Reduced |
| Millennium Management LLC | 23,995 | $25.4K | 0.00% | −131,394−84.6% | Reduced |
| Shay Capital LLC | 24,310 | $25.8K | 0.01% | +24,310 | New |
| Bank of America Corp | 29,147 | $30.9K | 0.00% | −5,559−16.0% | Reduced |
| Barclays PLC | 30,197 | $32.0K | 0.00% | 00.0% | Unchanged |
| HSBC Holdings PLC | 30,891 | $32.7K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 34,095 | $36.1K | 0.00% | +6,029+21.5% | Added |
| Velan Capital Investment Management LP | 35,000 | $37.1K | 0.04% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 44,758 | $47.4K | 0.00% | +44,758 | New |
| The PNC Financial Services Group, Inc. | 60,820 | $64.5K | 0.00% | −1,314−2.1% | Reduced |
| Walleye Capital LLC | 77,887 | $82.6K | 0.00% | −23,809−23.4% | Reduced |
| Panagora Asset Management Inc | 86,920 | $92.1K | 0.00% | −2,711−3.0% | Reduced |
| Goldman Sachs Group Inc | 95,073 | $100.8K | 0.00% | +4,810+5.3% | Added |
| ADAR1 Capital Management, LLC | 101,008 | $107.1K | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 115,657 | $122.6K | 0.00% | +8,311+7.7% | Added |
| UBS Group AG | 122,310 | $129.6K | 0.00% | −29,973−19.7% | Reduced |
| Evoke Wealth, LLC | 133,122 | $141.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 148,800 | $157.7K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 157,578 | $167.0K | 0.00% | 00.0% | Unchanged |
| RBF Capital, LLC | 245,561 | $260.3K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 256,431 | $271.8K | 0.00% | +242,311+1,716.1% | Added |
| Assenagon Asset Management S.A. | 263,059 | $278.8K | 0.00% | +148,021+128.7% | Added |
| Two Sigma Investments, LP | 291,455 | $308.9K | 0.00% | −61,772−17.5% | Reduced |
| Geode Capital Management, LLC | 432,704 | $458.8K | 0.00% | +1,912+0.4% | Added |
| Peapod Lane Capital LLC | 452,682 | $479.8K | 0.48% | −36,688−7.5% | Reduced |
| Two Sigma Advisers, LP | 485,700 | $514.8K | 0.00% | −19,900−3.9% | Reduced |
| Aldebaran Capital, LLC | 515,128 | $546.0K | 0.54% | −8,425−1.6% | Reduced |
| D. E. Shaw & Co., Inc. | 647,629 | $686.5K | 0.00% | −302,097−31.8% | Reduced |
| Stonepine Capital Management, LLC | 845,968 | $896.7K | 0.88% | +215,785+34.2% | Added |
| BlackRock, Inc. | 1,140,592 | $1.21M | 0.00% | −3,804−0.3% | Reduced |
| Acadian Asset Management LLC | 2,066,137 | $2.19M | 0.00% | +18,960+0.9% | Added |
| Vanguard Group Inc | 2,153,600 | $2.28M | 0.00% | −21,461−1.0% | Reduced |
| Alkeon Capital Management LLC | 2,342,373 | $2.48M | 0.01% | 00.0% | Unchanged |
| Euclidean Capital LLC | 2,627,643 | $2.79M | 0.91% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 3,188,116 | $3.38M | 0.06% | −120,561−3.6% | Reduced |
| Sio Capital Management, LLC | 3,735,396 | $3.96M | 1.59% | 00.0% | Unchanged |
| BML Capital Management, LLC | 5,000,000 | $5.30M | 4.06% | +1,252,388+33.4% | Added |
| OrbiMed Advisors LLC | 6,475,291 | $6.86M | 0.17% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −3,301,942−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −267,636−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −129,914−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −33,600−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −18,007−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −2,092−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −315−100.0% | Sold out |